Search

everythinglearnresearchcommunity

for

Search:↓

Nearly half of the French individuals surveyed reported having a sensitive scalp, more common in women, often linked to hair loss and symptoms like itching, and triggered by factors including shampoos and pollution.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Hair loss in secondary syphilis is more common than thought and can be reversed with antibiotics.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

COVID-19 may trigger sudden temporary hair loss.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

Low-dose naltrexone might be a cheap and effective additional treatment for hair loss with scalp discomfort due to its anti-inflammatory effects and few side effects.

Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.

The author clarifies that alopecia areata incognito and diffuse alopecia areata are different types of hair loss with unique symptoms and challenges in diagnosis.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

Many people with hair loss, especially those with telogen effluvium and alopecia areata, often have a sensitive scalp.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.

Some patients with hair loss after mild COVID-19 had positive tests for certain autoantibodies.

COVID-19 patients often experience temporary hair loss and scalp pain.

Telogen effluvium is a common, distressing condition causing excessive hair shedding and has significant psychological effects on patients.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

Most Iraqi women with telogen effluvium did not have a clear cause for their hair loss, and few had significant thinning.

Most Iraqi women with telogen effluvium had no clear cause for their hair loss, and few had significant thinning.

The study found that Temporal Triangular Alopecia often starts in early childhood, while Folliculitis Decalvans is characterized by tufted hairs and redness around hair follicles.

Hair casts are often mistaken for head lice, scalp pain in hair loss is linked to certain nerve factors, eyelash growth treatment is safe and effective, and nail shedding in children may follow hand-foot-mouth disease.

Hand-foot-mouth disease may cause nail loss in children.

Two women lost hair after mesotherapy for hair loss, with one having permanent and the other temporary hair loss.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Some people experienced hair loss after mesotherapy treatments for hair loss.